BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06819007-completion@plaintrial.com
DTSTAMP:20261027T144618Z
DTSTART;VALUE=DATE:20320131
SUMMARY:Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab
  Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer 
 (DESTINY-Ovarian01) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06819007
URL:https://plaintrial.com/trial/NCT06819007
END:VEVENT
END:VCALENDAR